202 related articles for article (PubMed ID: 24277465)
1. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
[TBL] [Abstract][Full Text] [Related]
2. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
[TBL] [Abstract][Full Text] [Related]
4. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
6. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
Breast Cancer Res; 2006; 8(4):R46. PubMed ID: 16859513
[TBL] [Abstract][Full Text] [Related]
7. [CXC chemokine receptor 4 regulates breast cancer cell cycle through S phase kinase associated protein 2].
Wang H; Chen T; Wang Y; Li Y; Zhang L; Ding Y; Chen S; Wang W; Yang Q; Chen C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 46(4):357-363. PubMed ID: 29256223
[TBL] [Abstract][Full Text] [Related]
8. Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.
Clement E; Inuzuka H; Nihira NT; Wei W; Toker A
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535262
[TBL] [Abstract][Full Text] [Related]
9. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
Tan Y; Zhou G; Wang X; Chen W; Gao H
Int J Oncol; 2018 Jul; 53(1):371-383. PubMed ID: 29749454
[TBL] [Abstract][Full Text] [Related]
10. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
11. Silencing of S-phase kinase-associated protein 2 enhances radiosensitivity of esophageal cancer cells through inhibition of PI3K/AKT signaling pathway.
Wang C; Li S; Liu J; Cheng M; Wang D; Wang Y; Lu B
Genomics; 2020 Sep; 112(5):3504-3510. PubMed ID: 32360515
[TBL] [Abstract][Full Text] [Related]
12. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
Radke S; Pirkmaier A; Germain D
Oncogene; 2005 May; 24(21):3448-58. PubMed ID: 15782142
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
15. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].
Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
[TBL] [Abstract][Full Text] [Related]
17. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
20. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
